Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar vs Depo Medrol for Synovial Inflammation in RA
NCT03511625Phase 3Active, not recruiting
- Sponsor
- Attune Health
- Start
- Oct 2018
- Primary completion
- Feb 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of corticotropin in rheumatoid arthritis (RA), sponsored by Attune Health. Started Oct 2018; status: active, not recruiting.
02
Drugs
corticotropin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03511625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03511625.